TIDMSYM
RNS Number : 9315L
Symphony Environmental Tech. PLC
16 September 2021
16 September 2021
SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC
("Symphony", the "Company" or the "Group")
Interim Results
Symphony Environmental Technologies Plc (AIM: SYM), a global
science-based group that makes plastic and rubber products
"smarter, safer and sustainable", is pleased to announce its
interim financial results for the six-month period ended 30 June
2021.
Financial highlights
-- Group revenue of GBP4.9 million (H1-2020: GBP4.8 million)
which on a constant-currency basis, would have shown a 13% increase
to GBP5.4 million
-- Gross profit of GBP1.9 million (H1-2020: GBP2.2 million) due
to higher proportion of finished goods in the product mix
-- Loss before tax of GBP0.6 million (H1-2020: profit GBP0.02 million)
-- Basic loss per share of 0.29 pence (H1-2020: earnings per share of 0.01 pence)
-- Cash generated in operations GBP0.3 million (H1-2020 cash used GBP0.6 million)
Business highlights
-- d2p - substantial progress in many product areas including an
increase in customer trials and product-tests currently underway.
Significant potential sales identified in many of the current
pipeline projects with a number expecting to commercialise in the
near term
-- Continued investment in Symphony's sales team, and new Head
of Innovation appointed to accelerate the commercialisation of the
Group's growing portfolio of new and highly innovative products.
Budgeted increase in one-off professional fees including legal,
communication, advocacy and external specialist technical costs to
assist with many key areas of the Group's activities, alongside
GBP0.05 million of non-budgeted increases in distribution and
shipping costs owing to short-term supply disruption
-- Several patent applications filed to protect our IP as many
new products reach commercialisation
Post period-end highlights
-- d2p - US FDA further approval for antibacterial plastic
technology with greater loading and wider use in bread films
-- d2p - Canadian Health approval for antibacterial bread films
-- 4 significant collaboration agreements with Meditech
o China distribution agreement for d2w and d2p
o Manufacturing and royalty agreement for Nitrile gloves
o Marketing agreement for Symphony to sell d2p Nitrile gloves in
specified markets
o Corporate agreement to acquire not less than 2.5% and not more
than 20% of Symphony's total share capital
Commenting on the results Nicolas Clavel, Interim Chairman of
Symphony, said:
During the period, the Group has substantially developed its
highly relevant product range together with continuing major
improvements in its key operations. This has resulted, amongst
other achievements, in US FDA and Canadian approvals for Symphony's
d2p bread packaging where the size of the market is vast, and where
Symphony already has a presence with its d2w biodegradable
technology. Other product areas are moving ahead strongly including
d2p antimicrobial in pipes and tanks, together with insect and
animal repellent technologies, amongst others. Symphony expects its
d2p bread packaging and some of its other d2p projects to
commercialise in the very near term.
The continuing investment in advisory and advocacy work is
strengthening the outlook for both d2w and d2p in Latin America and
the Middle East. In particular, the Saudi national standards
organisation, SASO, is increasing its enforcement of laws requiring
the use of oxo-biodegradable plastic, and we anticipate this will
lead to a substantial increase in demand during the second half of
the year.
The Far East sales position has also been strengthening, and
since the period end, the Group has augmented this by signing four
agreements with Meditech's Global Co Limited covering
manufacturing, distribution, and marketing in the region, together
with corporate investment in Symphony. The agreements also secure
glove supply using our antimicrobial and/or biodegradable
technologies for sales globally.
As reported in the trading update on 13 July 2021, revenues for
the 6 months ended 30 June 2021 were up marginally at GBP4.9
million (H1-2020: GBP4.8 million), but on a constant-currency
basis, would have been approximately 13% higher than in
H1-2020.
The Group continues to invest in its operations, in third party
consultancy and advocacy, and in R&D, and with this, the Board
is confident it is building a strong position to deliver meaningful
revenue growth in the short to medium term.
Michael Laurier, CEO of Symphony commented:
"The Group's strategy in the short to medium term is to focus on
delivering its innovative technologies for key identified product
lines where test results, trials and regulatory approvals have been
secured, and substantial sales opportunities have been
identified."
Enquiries:
Symphony Environmental Technologies Plc
Michael Laurier, CEO Tel: +44 (0) 20 8207
5900
Ian Bristow, CFO
www.symphonyenvironmental.com
Zeus Capital Limited (Nominated Adviser and
Joint Broker)
David Foreman / Nick Cowles / Kieran Russell Tel: +44 (0) 161
(Corporate Finance) 831 1512
Dominic King / Victoria Ayton (Sales) Tel: +44 (0) 203
829 5000
Hybridan LLP (Joint Broker)
Claire Louise Noyce Tel: +44 (0) 203
764 2341
The person responsible for arranging the release of this
information is Michael Laurier, CEO of the Company.
Chief Executive's review
Financial
Revenue for the 6 months ended 30 June 2021 was GBP4.9 million
(H1-2020: GBP4.8 million), but on a constant- currency basis, would
have been approximately 13% higher than the first half of 2020.
Gross margins were slightly lower due to an increased proportion
of finished products compared to higher margin masterbatches. Also,
distribution costs were higher during the period due to global
vessel and container shortages. This is expected to continue for
the remainder of the year.
As previously advised, cost continued in relation to supporting
d2w advocacy communications in the UK, Middle East and Latin
American markets. In addition, regulatory and other IP related
costs continued for new d2p products for the EU and US markets
together with legal costs pertaining to Symphony's ongoing claim
for very substantial damages against the EU.
The Company continues to invest in its sales and other key
operating functions to better manage its strong and growing
pipeline. A new and highly experienced Head of Innovation was
appointed during the period to work with the recently appointed
Head of Sales to strengthen the skill set of the sales and
procurement teams and to accelerate the commercialisation of
Symphony's growing portfolio of new and highly innovative
products.
This additional strategic investment in key resources, together
with the above-described factors resulted in a net loss before tax
of GBP0.6 million (H1-2020: profit GBP0.02 million).
An R&D tax credit of GBP127,000 was received during the
period (H1-2020: GBPnil). The Group reports a loss after tax of
GBP0.5 million (H1-2020 profit GBP0.02 million).
The loss per share for the period was 0.29 pence (H1-2020:
earnings per share of 0.01 pence).
d2p "Designed to Protect"
The Group has been successfully progressing its d2p sales
pipeline of over 100 projects, the majority of which are
customer-led and are moving towards commercialisation through
technical evaluation, agreeing commercial objectives, conducting
customer-trials, product testing and contract negotiation.
Customer-trials conducted during the period have incorporated
Symphony's d2p anti-microbial (also anti-viral), insecticidal,
odour and ethylene adsorbers, insect and animal repellent, and
flame retardant technologies. The trials have been for, inter alia,
the following products:
-- Food/bread
-- Pipes/tanks
-- PPE including gloves
-- Films for surface protection
-- Electric cables
-- Car components
-- Agricultural products
Many of the trials started during the period are expected to
complete over the coming months, and the Group has identified
substantial revenue potential within these current projects. The
Group is also continually receiving new enquires and therefore
anticipates its product pipeline will continue to grow strongly.
Our sales, technical and procurement teams have also designed and
implemented process improvements, particularly with regard to our
product-evaluation process, which is expected to shorten the period
significantly from enquiry to product commercialisation.
Enhanced FDA approval - subsequent approval by Health Canada
In July the Company received approval from the US Food &
Drug Administration ("FDA") for its d2p antimicrobial food contact
technology, for a much greater loading of the d2p technology, and
also wider use, further to Symphony's original bread-packaging
approval under FCN no. 2031, as announced on 26 February 2020 (RNS
number: 1106E).
The FDA's new approval for Symphony's d2p antimicrobial food
contact technology, now applies to all types of polyolefin and
polyester film for wrapping bread, instead of just linear low
density polythene ("LLDPE"). It now includes low density polythene
("LDPE") and polypropylene ("PP"), which are common packaging
materials. Symphony's d2p technology is intended to inhibit the
growth of bacteria on the surface of the packaging film and is
vital to a very hygiene-conscious industry.
This important wider approval, given under FCN no. 2139 without
limit of time, also allows up to three times increased loading of
d2p technology in an innovative treatment of the multi-layer
plastic films most commonly used in bread-packaging, giving greater
flexibility, efficacy and ultimately, greater value for Symphony's
customers and Symphony itself. The Board therefore anticipates an
acceleration of the commercial process in the near term.
Further to the FDA enhanced approval above, the same technology
was approved by Health Canada in September 2021. The Group has a
number of opportunities ongoing in Canada and other parts of the
world.
d 2w Oxo-biodegradable
The Group has seen stable end-user demand in its main markets,
although distributor and factory stock levels have been kept very
low due to global uncertainty caused by COVID-19 lockdowns. We
anticipate these ultra-low stock levels increasing to pre-pandemic
levels as the world moves out of lockdown.
The outlook for Latin America, the Middle East and some parts of
Asia is becoming much more positive as the vaccine programmes
continue to advance, and lock-down restrictions start to ease. In
addition, the advisory and advocacy work being carried out for d2w
technology in these countries is progressing well. As an example,
in the Middle East, the Saudi national standards organisation,
SASO, is increasing its enforcement of the laws which require the
use of oxo-biodegradable plastic, and we anticipate that this will
lead to a substantial increase in demand during H2-2021.
EU Action
Symphony's legal team has filed Replies to the Defences received
from the three defendants (the Commission, the Parliament, and the
Council of the European Union ("EU")) to the action it has brought
against them in the General Court of the EU. The Defendants now
have until 8 October 2021 to file their Rejoinders, and the
pleadings will then be closed. The next step is for the court to
fix a date for an oral hearing in Luxembourg. This is expected in
2022.
The Defences did not reveal anything unexpected, and Symphony's
legal team remain confident that the EU acted unlawfully in
imposing a ban on a material which they call "oxo-degradable
plastic" in Article 5 of the Directive. In any event, Symphony does
not accept that the ban applies to oxo-BIOdegradable plastics,
which are made by incorporating Symphony's d2w masterbatch into
ordinary plastic.
Patent Applications
In recognition of the growing pipeline of commercial projects
across the Group's product range, the Board believe now is the
appropriate time to invest both time and money in better protecting
its IP through the filing of patents. The Group has submitted
several patent applications during the period and will make further
announcements as appropriate in due course, as and when these
applications are approved.
Eranova
Eranova, with is sustainable algae sourced "plastic" technology,
continues with its pilot plant construction, which is on schedule
to complete during 2021.
Balance sheet and cashflow
The Group had net cash of GBP0.70 million at the end of the
period (30 June 2020: net cash of GBP0.29 million). Net cash of
GBP0.32 million was generated in operations (H1-2020: used in
operations GBP0.62 million) because of a decrease in receivables
since the year end.
The Group has an invoice discounting facility of GBP1.5 million
to assist in funding outstanding receivables when required. The
Board believes that the Group has sufficient working capital to
support the business and its current opportunities going
forward.
Brexit
At the current time, Brexit is not having a material impact on
the operations or financial performance of the Group. The Board
continues to monitor the Group's operations in the UK and Europe in
light of challenges arising from Brexit.
COVID-19
Although COVID-19 affected the markets in which Symphony
operates. So far, the negative effects to Group operations and
finances have been minimal, while the focus on hygiene has enhanced
interest in our d2p range. T here is still the possibility of
disruption to operations (customer or supplier disruption) or
finances (customer bad debt or ability of customers or suppliers to
carry on trading). The Group uses multiple supply sources and
continues in the main to credit-insure receivables or do business
on a letter of credit or proforma basis.
Outlook
After many years of product development, commercialisation of
key product lines is now expected in the very near term with
substantial sales growth anticipated. Further, we are encouraged by
the level of activity in many areas of the business worldwide,
covering many different product applications. Due to this expected
substantial growth, we are continuing to strengthen the Group's
operational teams as well as to further develop business
collaboration in a number of key markets. This, together with our
successes with regulatory clearances, is paving the way for a
strong outlook over the short to medium term.
Michael Laurier, Chief Executive
Condensed consolidated interim statement of comprehensive
income
6 months 6 months 12 months
to to to
30 June 30 June 31 December
2021 2020 2020
Unaudited Unaudited Audited
GBP'000 GBP'000 GBP'000
------------------------------ ------------ ---------- ------------
Revenue 4,878 4,753 9,766
Cost of sales (2,940) (2,594) (5,658)
------------------------------ ------------ ---------- ------------
Gross profit 1,938 2,159 4,108
Distribution costs (234) (164) (364)
Administrative expenses (2,303) (1,955) (4,136)
------------------------------ ------------ ---------- ------------
Operating (loss)/profit (599) 40 (392)
Finance costs (33) (22) (45)
------------------------------ ------------ ---------- ------------
(Loss)/profit for the period
before tax (632) 18 (437)
Tax credit 127 - 109
------------------------------ ------------ ---------- ------------
(Loss)/profit for the period (505) 18 (328)
------------------------------ ------------ ---------- ------------
Total comprehensive income
for the period (505) 18 (328)
------------------------------ ------------ ---------- ------------
Earnings per share:
Basic (0.29)p 0.01p (0.19)p
Diluted (0.29)p 0.01p (0.19)p
------------------------------ ------------ ---------- ------------
All results are attributable to the owners of the parent.
There were no discontinuing operations for any of the above
periods.
Condensed consolidated interim statement of financial
position
At At At
30 June 30 June 31 December
2021 2020 2020
Unaudited Unaudited Audited
GBP'000 GBP'000 GBP'000
-------------------------------------- ---------- ---------- ------------
ASSETS
Non-current
Property, plant and equipment 153 191 166
Right-of-use assets 621 573 510
Intangible assets 72 40 45
Investments 123 - 123
969 804 844
Current
Inventories 1,230 993 1,060
Trade and other receivables 2,573 3,316 3,614
Cash and cash equivalents 1,323 525 1,388
-------------------------------------- ---------- ---------- ------------
5,126 4,834 6,062
-------------------------------------- ---------- ---------- ------------
Total assets 6,095 5,638 6,906
-------------------------------------- ---------- ---------- ------------
EQUITY AND LIABILITIES
Equity
Equity attributable to owners
of
Symphony Environmental Technologies
plc
Share capital 1,768 1,700 1,768
Share premium account 3,185 2,077 3,185
Retained earnings (1,350) (519) (865)
-------------------------------------- ---------- ---------- ------------
Total equity 3,603 3,258 4,088
-------------------------------------- ---------- ---------- ------------
Liabilities
Non-current
Lease liabilities 411 446 381
-------------------------------------- ---------- ---------- ------------
Current
Borrowings 620 231 918
Lease liabilities 158 124 128
Trade and other payables 1,303 1,579 1,391
-------------------------------------- ---------- ---------- ------------
2,081 1,934 2,437
-------------------------------------- ---------- ---------- ------------
Total liabilities 2,492 2,380 2,818
-------------------------------------- ---------- ---------- ------------
Total equity and liabilities 6,095 5,638 6,906
-------------------------------------- ---------- ---------- ------------
Condensed consolidated interim statement of changes in
equity
Equity attributable to the owners of Symphony Environmental
Technologies plc:
Share Share Retained Total
capital premium earnings equity
GBP'000 GBP'000 GBP'000 GBP'000
--------------------------------- --------- --------- ---------- ---------
For the six months to 30
June 2021
Balance at 1 January 2021 1,768 3,185 (865) 4,088
Share-based payments - - 20 20
Transactions with
owners - - 20 20
------------------------ ------------------ --------- ---------- ---------
Total comprehensive income
for the period - - (505) (505)
--------------------------------- --------- --------- ---------- ---------
Balance at 30 June 2021 1,768 3,185 (1,350) 3,603
--------------------------------- --------- --------- ---------- ---------
Share Share Retained Total
capital premium earnings equity
GBP'000 GBP'000 GBP'000 GBP'000
------------------------------ --------- --------- ---------- ---------
For the six months to 30
June 2020
Balance at 1 January 2020 1,700 2,077 (537) 3,240
Total comprehensive income
for the period - - 18 18
------------------------------ --------- --------- ---------- ---------
Balance at 30 June 2020 1,700 2,077 (519) 3,258
------------------------------ --------- --------- ---------- ---------
Share Share premium Retained Total
capital earnings equity
GBP'000 GBP'000 GBP'000 GBP'000
-------------------------- --------------- -------------- ---------- --------
For the year to 31
December 2020
Balance at 1 January
2020 1,700 2,077 (537) 3,240
Issue of share capital 68 1,108 - 1,176
Transactions with
owners 68 1,108 - 1,176
-------------------------- --------------- -------------- ---------- --------
Total comprehensive
income for the year - - (328) (328)
-------------------------- --------------- -------------- ---------- --------
Balance at 31 December
2020 1,768 3,185 (865) 4,088
-------------------------- --------------- -------------- ---------- --------
Condensed consolidated interim cash flow statement
6 months 6 months 12 months
to to to
30 June 30 June 31 December
2021 2020 2020
Unaudited Unaudited Audited
GBP'000 GBP'000 GBP'000
--------------------------------- ----------- ----------- -------------
Operating activities:
(Loss)/profit for the period
after tax (505) 18 (328)
Depreciation 112 91 185
Amortisation 4 9 18
Profit on disposal of tangible
assets - (77) (67)
Share-based payments 20 - -
Foreign exchange (profit)/loss (11) (23) 37
Tax credit (127) - (109)
Interest paid 33 22 45
Change in inventories (170) (111) (178)
Change in trade and other
receivables 1,052 (981) (1,346)
Change in trade and other
payables (88) 437 301
--------------------------------- ----------- ----------- -------------
Net cash generated/(used)
in operations 320 (615) (1,442)
Tax received 127 - 109
--------------------------------- ----------- ----------- -------------
Net cash generated/(used)
in operating activities 447 (615) (1,333)
--------------------------------- ----------- ----------- -------------
Investing activities:
Additions to property, plant
and equipment (210) (12) (36)
Additions to intangible assets (31) (7) (21)
Additions to investments - - (123)
Proceeds from sale of property,
plant and equipment - 92 97
Net cash (used)/generated
in investing activities (241) 73 (83)
--------------------------------- ----------- ----------- -------------
Financing activities:
Movement in working capital
facility - 41 -
Movement in finance lease
liability 60 (61) (123)
Proceeds from share issue - - 1,176
Lease interest paid (14) (14) (27)
Bank and invoice finance
interest paid (19) (8) (18)
--------------------------------- ----------- ----------- -------------
Net cash generated/(used)
in financing activities 27 (42) 1,008
--------------------------------- ----------- ----------- -------------
Net change in cash and cash
equivalents 233 (584) (408)
Cash and cash equivalents,
beginning of period 470 878 878
Cash and cash equivalents,
end of period 703 294 470
--------------------------------- ----------- ----------- -------------
Represented by:
Cash and cash equivalents 1,323 525 1,388
Bank overdraft (620) (231) (918)
--------------------------------- ----------- ----------- -------------
703 294 470
--------------------------------- ----------- ----------- -------------
Notes to the interim financial statements
1 Nature of operations and general information
Symphony Environmental Technologies plc (the "Company") and
subsidiaries' (together the "Group") principal activities include
the development and supply of environmental plastic additives and
products.
Symphony Environmental Technologies plc, a public limited
company, is the Group's ultimate parent company. It is incorporated
and domiciled in England (company number 03676824). The address of
its registered office is 6 Elstree Gate, Elstree Way, Borehamwood,
Hertfordshire, WD6 1JD, England. The Company's shares are listed on
the AIM market of the London Stock Exchange.
These condensed interim consolidated financial statements
("interim financial statements" or "interim report") are for the
six months ended 30 June 2021. They do not include all of the
information required for full annual financial statements and
should be read in conjunction with the consolidated financial
statements of the Group for the year ended 31 December 2020.
The financial information set out in this interim report does
not constitute statutory accounts. The Group's statutory financial
statements for the year ended 31 December 2020 have been filed with
the Registrar of Companies. The auditor's report on those financial
statements was unqualified and did not contain a statement under
Section 498(2) or 498(3) of the Companies Act 2006. These interim
condensed consolidated financial statements have not been
audited.
These interim financial statements have been prepared in
accordance with the requirements of International Accounting
Standard ("IAS") 34 "Interim Financial Reporting", and are
presented in Pounds Sterling (GBP), which is the functional
currency of the parent company. They have been prepared under the
historical cost convention. They have also been prepared on the
basis of the recognition and measurement requirements of
International Financial Reporting Standards, and the policies and
measurements are consistent with those stated in the financial
statements for the year ended 31 December 2020.
These interim financial statements were approved by the board on
15 September 2021.
2 Significant accounting policies
These interim financial statements have been prepared in
accordance with the accounting policies adopted in the last annual
financial statements for the year ended 31 December 2020.
3 Seasonal fluctuations
The Group operates in many countries and in many different
markets. There are therefore no formal or considered seasonal
fluctuations affecting the operations of the Group.
4 Segmental analysis
The Board considers that the Group does not have separate
operating segments as defined under IFRS 8.
5 Shares issued
Shares issued are summarised as follows:
6 months 6 months Year to
to to 31 December
Shares issued and 30 June 30 June 2020
fully paid 2021 2020
------------------------ -------------- -------------- --------------
- beginning of period 176,751,277 170,026,277 170,026,277
- issued during the
period - - 6,725,000
------------------------- -------------- -------------- --------------
Total equity shares
issued and fully paid
at end of period 176,751,277 170,026,277 176,751,277
------------------------- -------------- -------------- --------------
6 Earnings per share and dividends
The calculation of earnings per share is based on the result
attributable to ordinary shareholders divided by the weighted
average number of shares in issue during the period.
The calculation of diluted earnings per share is based on the
basic earnings per share, adjusted to allow for the issue of shares
on the assumed conversion of dilutive options and warrants which
were exercisable during the period.
Reconciliations of the results and weighted average numbers of
shares used in the calculations are set out below:
Basic and diluted 6 months to 6 months Year to
30 June to 31 December
2021 30 June 2020
2020
-------------------------------- --------------- -------------- --------------
(Loss)/profit attributable GBP(505,000) GBP18,000 GBP(328,000)
to owners of the Company
Weighted average number
of ordinary shares in
issue 176,751,277 170,026,277 172,207,989
-------------------------------- --------------- -------------- --------------
Basic earnings per share (0.29) pence 0.01 pence (0.19)
pence
-------------------------------- --------------- -------------- --------------
Dilutive effect of weighted
average options and warrants 4,784,605 5,752,769 4,962,878
Total of weighted average
shares together with dilutive
effect of weighted options
and warrants 181,535,882 189,300,008 172,207,989
-------------------------------- --------------- -------------- --------------
Diluted earnings per share (0.29) pence 0.01 pence (0.19)
pence
-------------------------------- --------------- -------------- --------------
No dividends were paid for the year ended 31 December 2020.
The effect of options and warrants for the six months to 30 June
2021 and year to 31 December 2020 are anti-dilutive.
7 Availability of Interim Financial Statements
Paper copies of the Interim Financial Statements will be sent to
shareholders upon request. Shareholders will be able to download a
copy of the Interim Financial Statements from the Group's website
www.symphonyenvironmental.com . Further copies of the Interim
Financial Statements will be available from the Company's
Registered Office at 6 Elstree Gate, Elstree Way, Borehamwood,
Hertfordshire WD6 1JD.
NOTES TO EDITORS:
Symphony Environmental Technologies plc
https://www.symphonyenvironmental.com
Symphony has developed a range of additives, concentrates and
master-batches marketed under its d2p(R) ("designed to protect")
trademark, which can be incorporated in a wide variety of plastic
and non-plastic products so as to give them protection against many
different types of bacteria, viruses, fungi, algae, moulds, and
insects, and against fire. d2p products also include odour,
moisture, and ethylene adsorbers as well as other types of
food-preserving technologies. Symphony has also launched d2p
antimicrobial household gloves and toothbrushes and is developing a
range of other d2p finished products for retail sale.
Symphony has developed and continues to develop, a biodegradable
plastic technology which helps tackle the problem of microplastics
by turning ordinary plastic at the end of its service-life into
biodegradable materials. It is then no longer a plastic and can be
bioassimilated in the open environment in a similar way to a leaf.
The technology is branded d2w(R) and appears as a droplet logo on
many thousands of tonnes of plastic packaging and other plastic
products around the world. In some countries, most recently Saudi
Arabia, oxo-biodegradable plastic is mandatory for a wide range of
everyday products.
The Group has complemented its d2w biodegradable product range
with d2c "compostable resins and products" that have been tested to
US and EU composting standards.
Symphony has also developed the d2Detector(R), a portable device
which analyses plastics and detects counterfeit products. This is
useful to government officials tasked with enforcing legislation,
and Symphony's d2t tagging and tracer technology is available for
further security.
Symphony has a diverse and growing customer-base and has
established itself as an international business with 74
distributors around the world. Products made with Symphony's
plastic technologies are now available in nearly 100 countries and
in many different product applications. Symphony itself is
accredited to ISO9001 and ISO14001.
Symphony is a member of The OPA (www.biodeg.org) and actively
participates in the Committee work of the British Standards
Institute (BSI), the American Standards Organisation (ASTM), the
European Standards Organisation (CEN), and the International
Standards Organisation (ISO).
Further information on the Group can be found at
www.symphonyenvironmental.com and twitter @SymphonyEnv See also
Symphony on Instagram. A Symphony App is available for downloading
to smartphones.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IR LELLFFKLLBBZ
(END) Dow Jones Newswires
September 16, 2021 02:00 ET (06:00 GMT)
Symphony Environmental T... (LSE:SYM)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Symphony Environmental T... (LSE:SYM)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
